Pediatric Array CGH Analysis ( Cyto–500+ )

Phalanx Biotech collaborated with clinicians and genetic medicine experts in the design and development of pediatric chromosomal microarray to detect DNA microamplification and microdeletions within the full genome. This one microarray provides screening for 500+ hereditary disorders arising from CNVs, and features excellent discriminative power and sensitivity.

Pediatric Array CGH Analysis ( Cyto – 500+ )

Two primary mutations in human genome

Five genetic factors of developmental delay

Integrated genetic disorder testing service

By combining the advantages of “Pediatric Array CGH Analysis ( Cyto - 500+ )” and “Whole Exome Sequencing (WES) for DD/ID”, it is possible to conduct efficient investigation on the cause of disorders including CNVs and SNVs. The result of analysis supports the physician in determining the condition and providing the best management.

Genetic disease testing

Recommended Subjects

Individuals with clinical manifestation, for example, developmental delay or intellectual disability, who is not otherwise diagnosed.
Unknown cause, unable to be specified via clinical means, seeks to rule out the possibilities of gene abnormality.
Familial history of births with other genetic disorder, chromosomal disorder or congenital defect.

Test procedure

1
The physician collects 1-3 ml blood (or 0.2 ml from baby heel)
2
Write the consent form
3
Deliver to laboratory
4
Laboratory test and data analysis
5
Report provided by the physician